Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
Chammartin F, Mocroft A, Egle A, Zangerle R, Smith C, Mussini C, Wit F, Vehreschild JJ, d'Arminio Monforte A, Castagna A, Bailly L, Bogner J, de Wit S, Matulionyte R, Law M, Svedhem V, Tallada J, Garges HP, Marongiu A, Borges ÁH, Jaschinski N, Neesgaard B, Ryom L, Bucher HC; RESPOND Study Group. Chammartin F, et al. Among authors: marongiu a. Clin Infect Dis. 2024 Apr 10;78(4):995-1004. doi: 10.1093/cid/ciad671. Clin Infect Dis. 2024. PMID: 38092042 Free PMC article.
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
Esser S, Brunetta J, Inciarte A, Levy I, D'Arminio Monforte A, Lambert JS, van Welzen B, Teruya K, Boffito M, Liu CE, Altuntas Aydın O, Thorpe D, Heinzkill M, Marongiu A, Cassidy T, Haubrich R, D'Amato L, Robineau O. Esser S, et al. Among authors: marongiu a. HIV Med. 2024 Apr;25(4):440-453. doi: 10.1111/hiv.13593. Epub 2023 Dec 26. HIV Med. 2024. PMID: 38148567
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study.
Wong A, Brunetta J, De Wet J, Logue K, Loemba H, Saifi T, Mumm D, Marongiu A, Harrison R, Thorpe D, Trottier B. Wong A, et al. Among authors: marongiu a. Medicine (Baltimore). 2024 Apr 19;103(16):e37785. doi: 10.1097/MD.0000000000037785. Medicine (Baltimore). 2024. PMID: 38640301 Free PMC article.
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose.
Sanna G, Marongiu A, Firinu D, Piras C, Palmas V, Galdiero M, Atzori L, Caria P, Campagna M, Perra A, Costanzo G, Coghe F, Littera R, Chessa L, Manzin A. Sanna G, et al. Among authors: marongiu a. Clin Exp Med. 2024 Jan 20;24(1):12. doi: 10.1007/s10238-023-01276-x. Clin Exp Med. 2024. PMID: 38244064 Free PMC article.
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer.
Bianconi F, Salis R, Fravolini ML, Khan MU, Minestrini M, Filippi L, Marongiu A, Nuvoli S, Spanu A, Palumbo B. Bianconi F, et al. Among authors: marongiu a. Sensors (Basel). 2023 Sep 18;23(18):7952. doi: 10.3390/s23187952. Sensors (Basel). 2023. PMID: 37766009 Free PMC article.
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study.
De Feo MS, Frantellizzi V, Bauckneht M, Farcomeni A, Filippi L, Rizzini EL, Lavelli V, Stazza ML, Di Raimondo T, Fornarini G, Rebuzzi SE, Filippo M, Mammucci P, Marongiu A, Monari F, Rubini G, Spanu A, De Vincentis G. De Feo MS, et al. Among authors: marongiu a. Biomedicines. 2023 Apr 5;11(4):1103. doi: 10.3390/biomedicines11041103. Biomedicines. 2023. PMID: 37189721 Free PMC article.
89 results